GV and ADM Ventures Investments Corp contributed to the online farming community and services provider’s series G round at a $3.9bn valuation.
Month: November 2021
EasyHealth seizes $135m
Nationwide Ventures participated in a round for the Medicare brokerage made up of $35m in equity financing and a $100m credit facility.
Redaptive files for IPO
The CBRE, Engie, Great Plains Energy and Evergy-backed energy efficiency technology provider is eyeing a listing on the New York Stock Exchange.
Kandji verifies $100m series C round
The device management platform developer closed its third round in two years with backing from Okta Ventures.
Treadwell Therapeutics steps to series B round
Sino Biopharmaceutical co-led the oncology treatment developer’s latest round, in which it raised over $91m in funding.
Samba TV dances toward public markets
Liberty Global, A+E Networks, WarnerMedia, Interpublic and MDC Partners are all in line to exit the television data provider through its initial public offering.
Go Fashion dresses up with pre-IPO funding
SBI Life was among the 33 anchor investors that backed the legwear brand’s $61.2m round, disclosed the day before the latter went public.
Overwolf catches investors for $75m series D
Intel Capital and Liberty Technology Venture Capital have returned to back the game development platform’s latest round, which pushed its total funding past the $150m mark.
Ultraleap captures $81m in series D funding
Tencent helped the motion tracking technology developer secure series D funding that will go to product development and commercialisation.
Analysis: Oil & gas trends in Q3 2021
We are offering a small excerpt from our latest quarterly report on corporate venturing in the oil and gas space.
Daily Deal Round Up: November 19, 2021
Autonomous driving technology developer MaxiEye bagged nearly $50m in a Desay-led round while software testing technology producer Mabl raised $40m from investors including GV and Presidio Ventures.
Lacework leans into $1.3bn
The cybersecurity technology producer was valued at $8.3bn in a round that included existing backers Liberty Global Ventures and Snowflake Ventures.
Sanofi sends $180m to Owkin
Cancer research software provider Owkin received the funding as part of a strategic collaboration partnership which will involve it working with Sanofi on potential treatments.
Expel gets series E $140m injection
Subsidiaries of Alphabet and Cisco were among the investors which pushed the cybersecurity technology provider to unicorn status.